Slashdot Mirror
Drug Halts Decline In Alzheimer's Patients
ljw1004 writes "Alzheimer's researchers are divided on whether the disease is caused by 'beta amyloid' (a peptide found in Alzheimer brains) or by 'tau protein' (normally used for cellular scaffolding, but can aggregate out of control and destroy neurons). Today in Chicago a new drug has been announced that stops tau aggregation and appears to have halted Alzheimer's-related decline in 300 clinical trial patients. The drug is known as 'rember.' Do you have friends or family who appear to be on the road to dementia? Here is an online questionnaire, part of one used in the clinical trial to diagnose dementia. (Disclosure: I made the online questionnaire, and my father is one of the scientists behind the drug.)"
(I'm a PhD Neuroscience student) It seems like more and more scientists are moving away from the beta amyloid plaque buildup hypthesis. While it seemed like a great lead, people who die with no symptoms of dementia or Alzheimer's Disease can still have a buildup of beta amyloid plaque as massive as the person who did die of Alzheimer's. It could be that high levels of beta amyloid plaque buildup increases the risk of getting Alzheimer's, though. It's a hard disease to crack, that's for sure. If this new drug really does work, it'll save 5 million lives a year, and that's just in the past few years; as the Baby Boomers all get past 65 we're going to start seeing a massive increase in Alzheimer's Disease.